A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay

por Batra, Rahul, Olivieri, Luis Gonzalez, Rubin, Delfin, Vallari, Ana, Pearce, Sandra, Olivo, Ana, Prostko, John, Nebbia, Gaia, Douthwaite, Sam, Rodgers, Mary, Cloherty, Gavin
Publicado 2020

SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood

por Ng, Dianna L., Goldgof, Gregory M., Shy, Brian R., Levine, Andrew G., Balcerek, Joanna, Bapat, Sagar P., Prostko, John, Rodgers, Mary, Coller, Kelly, Pearce, Sandra, Franz, Sergej, Du, Li, Stone, Mars, Pillai, Satish K., Sotomayor-Gonzalez, Alicia, Servellita, Venice, Martin, Claudia Sanchez San, Granados, Andrea, Glasner, Dustin R., Han, Lucy M., Truong, Kent, Akagi, Naomi, Nguyen, David N., Neumann, Neil M., Qazi, Daniel, Hsu, Elaine, Gu, Wei, Santos, Yale A., Custer, Brian, Green, Valerie, Williamson, Phillip, Hills, Nancy K., Lu, Chuanyi M., Whitman, Jeffrey D., Stramer, Susan L., Wang, Candace, Reyes, Kevin, Hakim, Jill M. C., Sujishi, Kirk, Alazzeh, Fariba, Pham, Lori, Thornborrow, Edward, Oon, Ching-Ying, Miller, Steve, Kurtz, Theodore, Simmons, Graham, Hackett, John, Busch, Michael P., Chiu, Charles Y.
Publicado 2020